GSK GSK plc
- Official Name: GSK PLC
- Headquarters: 2929 Walnut St, Philadelphia, PA 19104, US
- CEO: Emma Walmsley
- Website: gsk.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Won by 0.649 | (0.027) - (0.676) | ||
| 2025-07-21 | 2 | Lost by 4.349 | (0.485) - 3.864 | ||
| 2025-07-23 | 1R | Won by 2.711 | 2.503 - (0.208) | ||
| 2025-07-28 | 3 | Won by 0.527 | 2.979 - 2.452 | ||
| 2025-07-29 | 2R | Lost by 1.620 | 1.149 - 2.769 | ||
| 2025-08-04 | 4 | Won by 1.711 | 0.937 - (0.774) | ||
| 2025-08-06 | 2R | Lost by 1.410 | (1.395) - 0.015 | ||
| 2025-08-11 | 5 | Won by 4.116 | 1.161 - (2.955) | ||
| 2025-08-18 | 6 | Won by 0.482 | 4.454 - 3.972 | ||
| 2025-08-25 | 7 | Won by 2.936 TOTW | 5.317 - 2.381 | ||
| 2025-09-01 | 8 | Lost by 0.001 | 0.114 - 0.115 | ||
| 2025-09-08 | 9 | Won by 1.789 | 1.044 - (0.745) | ||
| 2025-09-15 | 10 | Won by 1.987 | 0.584 - (1.403) | ||
| 2025-09-22 | 11 | Won by 0.975 | 1.475 - 0.500 | ||
| 2025-09-29 | 12 | Won by 1.335 | 0.469 - (0.866) | ||
| 2025-10-06 | 13 | Won by 3.710 | 3.005 - (0.705) | ||
| 2025-10-13 | 14 | Won by 0.688 | 0.569 - (0.119) | ||
| 2025-10-20 | 15 | Won by 0.446 | 1.004 - 0.558 |
Latest News
SeekingAlpha - 2026-08-31
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
SeekingAlpha - 2026-08-31
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more a...
Show more
SeekingAlpha - 2026-08-27
GSK: Still One Of My Top Healthcare Picks
Benzinga - 2026-08-25
FDA Approves Drug To Treat HIV Infection in Newborns
Benzinga - 2026-08-25
Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?
Benzinga - 2026-08-23
Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy
SeekingAlpha - 2026-08-20
Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance
Benzinga - 2026-08-14
9 Health Care Stocks Whale Activity In Today’s Session
SeekingAlpha - 2026-08-13
Wall Street Lunch: Trump's MMR Split Plan Faces FDA, Manufacturing Hurdles
Benzinga - 2026-08-11
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga - 2026-08-10
Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong'
Benzinga - 2026-08-10
Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
Benzinga - 2026-08-10
'Trump Trump Administration Is Working On An Executive Order That Would Split Childhood MMR Vaccine Into Three Shots And Delivering Vaccines At Separate Medical Visits' - Axios
SeekingAlpha - 2026-08-10
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
Benzinga - 2026-08-07
Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'
SeekingAlpha - 2026-07-31
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run
Benzinga - 2026-07-29
GSK Announces Cabenuva Demonstrates Superiority To Daily Oral Therapy In Adolescents Living With HIV, As Viiv Healthcare Highlights New Long-Acting Injectable Data At AIDS 2026
SeekingAlpha - 2026-07-28
GSK plc (GSK) Q2 2026 Earnings Call Transcript
Benzinga - 2026-07-28
GSK Races To Protect Profits Before Its HIV Blockbuster Faces Generic Rivals
SeekingAlpha - 2026-07-28
GSK: Healthy Results, But Limited Stock Upside (Rating Downgrade)
Benzinga - 2026-07-28
GSK Investing £400M To Establish New R&D Center In Cambridge, U.K.
Benzinga - 2026-07-28
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
SeekingAlpha - 2026-07-28
GSK plc 2026 Q2 - Results - Earnings Call Presentation
Benzinga - 2026-07-28
GSK FY2031 Revenue expected to be more than $53.204B vs $45.690B Est
Benzinga - 2026-07-28
GSK Affirms FY2026 Adj EPS Guidance of $4.90-$5.00 vs $4.79 Est; Affirms FY2026 Sales Guidance of $44.754B vs $45.690B Est
Benzinga - 2026-07-28
GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate
Benzinga - 2026-07-28
GSK Licensor Hansoh Pharma Announces Results From Second Phase III Trial For Ris-Rez In China; Study Met Its Primary Endpoint Of Progression-Free Survival In Relapsed Osteosarcoma
Benzinga - 2026-07-24
GSK Canada Receives Approval For Shingrix Zoster Vaccine In Prefilled Syringe
Benzinga - 2026-07-22
FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule
Benzinga - 2026-07-22
GSK Wins FDA Approval For Jideytro To Treat Previously Treated ROS1-Positive Non-Small Cell Lung Cancer
Benzinga - 2026-07-21
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US
SeekingAlpha - 2026-07-21
GSK: Buy The Discount Before The Catalysts Close It
SeekingAlpha - 2026-07-20
Eikon Therapeutics: Behind The Rough Debut
SeekingAlpha - 2026-07-18
AI Bubble Risks Make Dividend Stocks Attractive Again
Benzinga - 2026-07-17
Disappointing Data Prompts GSK to Drop Cough Drug Development
Benzinga - 2026-07-17
GSK Plans To Stop Further Development Of Camlipixant In Refractory Chronic Cough As Camlipixant 25mg Twice Daily Failed To Meet Statistical Significance In CALM-1, CALM-2 Clinical Trials
SeekingAlpha - 2026-07-16
Europe's Other Story: 5 Reasons The Continent's Equities Are Worth A Closer Look
Benzinga - 2026-07-14
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga - 2026-07-13
GSK's Jemperli May Help Some Rectal Cancer Patients Avoid Surgery
Benzinga - 2026-07-10
GSK Adds Positive Phase 3 Lung Cancer Data, Ends Alector Partnership
SeekingAlpha - 2026-07-09
GSK Walks Away From Alector - Pipeline Reset Story Begins
Benzinga - 2026-07-08
GSK Terminates Collaboration, License Agreement With Alector, Effective Jan. 2, 2027; Alector Repays $10.429M
Benzinga - 2026-07-08
Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
Benzinga - 2026-07-05
Warren Says Trump's Law Pushed 2 Million-Plus Children Off Medicaid, CHIP Across States
SeekingAlpha - 2026-06-25
Is GSK Quietly Becoming An Oncology Powerhouse
Benzinga - 2026-06-24
GSK Commences Tender Offer To Acquire Nuvalent At $124/Share
SeekingAlpha - 2026-06-23
Moderna: From Buy To Sell After 128.2% Surge (Rating Downgrade)
SeekingAlpha - 2026-06-23
Moderna: The Comeback Is Now In Full Swing
SeekingAlpha - 2026-06-18
Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering
Benzinga - 2026-06-17
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
Benzinga - 2026-06-17
GSK, Spero Therapeutics Announce FDA Approves Utebzi To Treat Complicated Urinary Tract Infections
Benzinga - 2026-06-16
GSK's Exdensur Receives Canada Approval To Treat Severe Asthma, Chronic Rhinosinusitis With Nasal Polyps
Benzinga - 2026-06-12
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga - 2026-06-12
GSK's Momelotinib Receives Orphan Drug Designation From FDA And European Medicines Agency For VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
SeekingAlpha - 2026-06-11
Nuvalent: 'Hold' On GlaxoSmithKline Acquisition For Selective Tyrosine Kinase Inhibitors
SeekingAlpha - 2026-06-10
GSK plc (GSK) M&A Call Transcript
SeekingAlpha - 2026-06-09
GSK plc (GSK) Nuvalent, Inc. - M&A Call - Slideshow
Benzinga - 2026-06-09
Nasdaq 100 Tumbles Over 3%, Marvell Crashes 12%: Stock Market Today
Benzinga - 2026-06-09
GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent
Benzinga - 2026-06-09
GSK Enters Agreement To Acquire Nuvalent For $10.6B At $124 Per Share, A 40% Premium To Last Closing Price
SeekingAlpha - 2026-06-05
Amgen: Time For An Upgrade? Yes, I Think So
Benzinga - 2026-06-04
8 Stocks Moving In Wednesday's After-Hours Session
SeekingAlpha - 2026-06-03
GSK plc (GSK) Presents at Jefferies Global Healthcare Conference 2026 Transcript
SeekingAlpha - 2026-06-02
Madrigal Pharmaceuticals Could Become The Next Vertex
SeekingAlpha - 2026-05-28
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
SeekingAlpha - 2026-05-28
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment - Slideshow
Benzinga - 2026-05-28
GSK Announces UK's NICE Issues Guidance Recommending Nucala For Use On The NHS For Uncontrolled COPD Patients
SeekingAlpha - 2026-05-28
Eli Lilly Expands Into Infectious Diseases, Retatrutide Adds Another Phase 3 Win
SeekingAlpha - 2026-05-25
GSK: Improved Prospects After Correction
Yahoo - 2026-05-22
GSK’s Expanded Arexvy Label And Deals Add Context To Valuation Gap
Yahoo - 2026-05-22
Here's Why GSK (GSK) is a Strong Value Stock
Yahoo - 2026-05-22
Here's Why You Should Add SMMT Stock to Your Portfolio Now
Yahoo - 2026-05-21
GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?
SeekingAlpha - 2026-05-21
Why Gilead Sciences Is Now A Hold (Rating Upgrade)
SeekingAlpha - 2026-05-20
Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data
ChartMill - 2026-05-19
GSK PLC-SPON ADR (NYSE:GSK) Passes Quality-Focused Caviar Cruise Stock Screener with Strong Profitability and Cash Flow
Yahoo - 2026-05-15
Benlysta Sales Forecast and Market Size Analysis Report 2026-2034 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
SeekingAlpha - 2026-05-12
GSK plc (GSK) Shareholder/Analyst Call - Slideshow
Yahoo - 2026-05-12
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading
Yahoo - 2026-05-12
GSK China Hepatitis B Alliance Puts Bepirovirsen And Valuation In Focus
Yahoo - 2026-05-11
Ambirix (GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Benzinga - 2026-05-11
GSK Targets China's Hepatitis B Market Through New Deal
Yahoo - 2026-05-08
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
Yahoo - 2026-05-08
GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View
SeekingAlpha - 2026-05-08
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Benzinga - 2026-05-08
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants' - Reuters Exclusive
Yahoo - 2026-05-07
Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
Benzinga - 2026-05-07
Halozyme Therapeutics Signs License Agreement With GSK For ENHANZE Drug Delivery Technology To Develop, Commercialize Subcutaneous Administration Of Multiple Oncology Targets
Yahoo - 2026-05-06
Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical Summit
Benzinga - 2026-05-06
Tempus AI's Big Pharma AI Partnerships Are Getting Bigger And Stickier
Yahoo - 2026-05-06
GSK's (LON:GSK) Performance Is Even Better Than Its Earnings Suggest
Yahoo - 2026-05-05
Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
SeekingAlpha - 2026-05-05
AI Revolutionizing Biopharma: Faster, Better, Cheaper
Yahoo - 2026-05-04
SMMT Q1 Loss Narrower Than Expected, Stock Down on Ivonescimab Setback
Benzinga - 2026-05-01
GSK's Linerixibat Receives Medicines And Healthcare Products Regulatory Agency Approval To Treat Itch Due To Biliary Tract Disease
Benzinga - 2026-04-30
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
SeekingAlpha - 2026-04-29
GSK plc (GSK) Q1 2026 Earnings Call Transcript
SeekingAlpha - 2026-04-29
Regeneron Pharmaceuticals: Q1 Beat Driven By Dupixent And Eylea HD Strength
SeekingAlpha - 2026-04-29
GSK plc 2026 Q1 - Results - Earnings Call Presentation
Benzinga - 2026-04-29
Earnings Scheduled For April 29, 2026
Benzinga - 2026-04-29
Vaccine Star Shingrix Lifts GSK, But Weak Segments Raise Eyebrows
Benzinga - 2026-04-28
GSK Reaffirms 2026 Guidance With 3%-5% Turnover Growth And 7%-9% Core EPS Growth, Eyes £40B+ Sales By 2031
Benzinga - 2026-04-28
GSK Q1 Adj. EPS $1.25 Beats $1.17 Estimate, Sales $10.222B Beat $10.190B Estimate
SeekingAlpha - 2026-04-28
SBIO: Leaning Into Drug Discovery And Medical Breakthroughs
Benzinga - 2026-04-27
GSK's Bepirovirsen Receives FDA Priority Review And Breakthrough Therapy Designation For Chronic Hepatitis B With PDUFA Date Of October 26
Benzinga - 2026-04-27
AnaptysBio Stock Rallies As Delaware Court Tosses Tesaro Breach Claim
Benzinga - 2026-04-27
GSK's Efimosfermin Receives FDA's Breakthrough Therapy Designation, European Medicines Agency's Priority Medicines Designation To Treat Metabolic Dysfunction-Associated Steatohepatitis
Benzinga - 2026-04-27
Alfasigma Completes License Agreement With GSK To Develop, Manufacture, Commercialise Linerixibat
Benzinga - 2026-04-24
AnaptysBio Wins Court Ruling Upholding Jemperli Royalties, Trial Vs. Tesaro/GSK Set For July 14–17, 2026
SeekingAlpha - 2026-04-21
AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics
Benzinga - 2026-04-21
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk
SeekingAlpha - 2026-04-20
Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't
Benzinga - 2026-04-20
GSK's Blenrep Receives China's National Medical Products Administration Approval To Treat Adults With Relapsed Or Refractory Multiple Myeloma
SeekingAlpha - 2026-04-20
What To Expect From Sanofi In Q1 2026
SeekingAlpha - 2026-04-19
GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential
SeekingAlpha - 2026-04-13
Wall Street Breakfast Podcast: Flight Cuts Deepen On Fuel Shock
Benzinga - 2026-04-13
GSK Reports Promising Early Data For Experimental Cancer Drug
Benzinga - 2026-04-13
Reported Earlier, GSK's Mocertatug Rezetecan Achieves 62% Response Rate In Platinum-Resistant Ovarian Cancer And 67% In Endometrial Cancer In Phase 1 BEHOLD-1 Trial
Benzinga - 2026-04-07
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker
SeekingAlpha - 2026-04-06
Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative
Benzinga - 2026-04-02
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report
Benzinga - 2026-04-01
GSK's Partner Shionogi Acquires Pfizer's Stake In ViiV Healthcare For $2.125B
SeekingAlpha - 2026-03-31
GSK: Chinese Expansion And Fine Financials
Benzinga - 2026-03-30
GSK Receives China's National Medical Products Administration Approval For Exdensur To Treat Severe Asthma Characterised By An Eosinophilic Phenotype
Benzinga - 2026-03-27
AnaptysBio Announces $100M Buyback Plan; Announces To Manage Financial Partnership For Jemperli With GSK And Imsidolimab With Vanda After Planned Spin-Off Of First Tracks Biotherapeutics
Benzinga - 2026-03-26
GSK's Bepirovirsen Enters EMA Review As Potential First-In-Class Functional Cure For Chronic Hepatitis B With Statistically Significant Phase III Results
Benzinga - 2026-03-26
Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data?
SeekingAlpha - 2026-03-26
GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
Benzinga - 2026-03-23
GSK Receives Japan's Orphan Drug Designation For Risvutatug Rezetecan To Treat Small-Cell Lung Cancer
SeekingAlpha - 2026-03-23
Dividend Income: Lanny's January 2026 Summary
Benzinga - 2026-03-20
Medicare Chief Chris Klomp Optimistic On CDC Director Search As Vaccine Fight Roils Agency— 'We Will Select...'
SeekingAlpha - 2026-03-18
Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
SeekingAlpha - 2026-03-18
GSK Expanding Fast - Oncology, HIV, And Smart Acquisitions
Benzinga - 2026-03-17
Federal Judge Flags Legal Flaws In RFK Jr.'s Vaccine Overhaul
Benzinga - 2026-03-16
U.S. Judge Blocks Trump Administration's Cuts To Number Of Routinely Recommended Vaccines For Children, Blocks Appointments Of 13 Members To Vaccine Panel
Benzinga - 2026-03-16
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Benzinga - 2026-03-13
FDA Broadens Access To GSK's Respiratory Syncytial Virus Shot For Younger High-Risk Adults
Benzinga - 2026-03-13
GSK's Arexvy Vaccine Now Cleared By FDA For Younger Adults Vulnerable To RSV
SeekingAlpha - 2026-03-11
GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
SeekingAlpha - 2026-03-10
Moderna: Pipeline Hope Won't Pay The Bills
Benzinga - 2026-03-10
FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder
Benzinga - 2026-03-08
GSK Licenses Linerixibat To Alfasigma For $300M Upfront Plus Up To $390M In Milestones And Tiered Double-Digit Royalties For Worldwide PBC Cholestatic Pruritus Rights
Benzinga - 2026-03-05
Stocks Trading Ex Dividend For Mon., Nov. 19, 2018
Benzinga - 2026-03-05
Shares of pharmaceutical companies are trading lower amid overall market weakness due to the ongoing conflict in the Middle East.
Benzinga - 2026-03-04